Choose Your Country or Region

A20/TNFAIP3 (J7N7) Rabbit mAb

Catalog No.: F3346

Experiment Essentials

Subcellular Location: Cytoplasm, Lysosome, Nucleus.
WB
Recommending using RIPA/NP-40 Lysis Buffer to prepare lysates.

Usage Information

Dilution
WB1:1000-1:5000 IHC1:50 - 1:100

Application
WB, IHC

Source
Rabbit

Reactivity
Human, Mouse

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
89 kDa

Exprimental Methods

WB
Experimental Protocol: Sample preparation 1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail)，and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes. 2. Adherent cell: Aspirate the culture medium and transfer the cells into an EP tube. Wash the cells with ice-cold PBS twice. Add an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail), sonicate to lyse the cells, and incubate on ice for 30 minutes. 3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice.Add an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail), sonicate to lyse the cells, and incubate on ice for 30 minutes. 4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant; 5. Remove a small volume of lysate to determine the protein concentration; 6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice. Electrophoretic separation 1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations 2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.) Transfer membrane 1. Take out the converter, soak the clip and consumables in the pre-cooled converter; 2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer; 3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip"; 4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications Recommended conditions for wet transfer: 200 mA, 120 min. ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.) Block 1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes; 2. Incubate the film in the blocking solution for 1 hour at room temperature; 3. Wash the film with TBST for 3 times, 5 minutes each time. Antibody incubation 1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight; 2. Wash the film with TBST 3 times, 5 minutes each time; 3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour; 4. After incubation, wash the film with TBST 3 times for 5 minutes each time. Antibody staining 1389. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly; 2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system. (Exposure time of at least 60s is recommended)

Experimental Protocol:

Sample preparation

1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail)，and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.

2. Adherent cell: Aspirate the culture medium and transfer the cells into an EP tube. Wash the cells with ice-cold PBS twice. Add an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail), sonicate to lyse the cells, and incubate on ice for 30 minutes.

3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice.Add an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail), sonicate to lyse the cells, and incubate on ice for 30 minutes.

4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;

5. Remove a small volume of lysate to determine the protein concentration;

6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.

Electrophoretic separation

1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations

2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)

Transfer membrane

1. Take out the converter, soak the clip and consumables in the pre-cooled converter;

2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;

3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";

4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications

Recommended conditions for wet transfer: 200 mA, 120 min.

( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)

Block

1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;

2. Incubate the film in the blocking solution for 1 hour at room temperature;

3. Wash the film with TBST for 3 times, 5 minutes each time.

Antibody incubation

1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;

2. Wash the film with TBST 3 times, 5 minutes each time;

3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;

4. After incubation, wash the film with TBST 3 times for 5 minutes each time.

Antibody staining

1389. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;

2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system. (Exposure time of at least 60s is recommended)

Datasheet & SDS

Biological Description

Specificity
TNFAIP3 Rabbit mAb recognizes endogenous levels of total TNFAIP3 protein.

Synonym(s)
A20/TNFAIP3,TNFAIP3

Clone
J7N7

Background
TNFAIP3 (A20) is a critical ubiquitin-editing enzyme encoded by the TNFAIP3 gene, functioning as a key negative regulator of inflammation and immune responses. It is rapidly induced by pro-inflammatory stimuli such as TNF-α, IL-1β, and LPS, and primarily acts to terminate NF-κB signalling. TNFAIP3 contains an N-terminal ovarian tumor (OTU) domain with deubiquitinating (DUB) activity and multiple zinc finger (ZnF) motifs in the C-terminal region, which confer E3 ubiquitin ligase and ubiquitin-binding capabilities. This dual function allows TNFAIP3 to remove K63-linked ubiquitin chains from signalling intermediates like RIP1 and TRAF6 and add K48-linked chains, targeting them for proteasomal degradation. By editing these ubiquitin chains, TNFAIP3 inhibits the sustained activation of NF-κB and MAPK pathways, thus preventing excessive inflammation. TNFAIP3 also exhibits anti-apoptotic properties, particularly in pancreatic β-cells and vascular endothelial cells, contributing to cell survival under inflammatory stress. Loss-of-function mutations or decreased expression of TNFAIP3 is associated with heightened susceptibility to autoimmune diseases, chronic inflammatory disorders, and various cancers, particularly B-cell lymphomas. It serves as a tumor suppressor by repressing constitutive NF-κB activity, which drives cell proliferation and survival. Genetic variants in TNFAIP3 are implicated in diseases such as systemic lupus erythematosus, rheumatoid arthritis, psoriasis, and atherosclerosis.

Background

TNFAIP3 (A20) is a critical ubiquitin-editing enzyme encoded by the TNFAIP3 gene, functioning as a key negative regulator of inflammation and immune responses. It is rapidly induced by pro-inflammatory stimuli such as TNF-α, IL-1β, and LPS, and primarily acts to terminate NF-κB signalling. TNFAIP3 contains an N-terminal ovarian tumor (OTU) domain with deubiquitinating (DUB) activity and multiple zinc finger (ZnF) motifs in the C-terminal region, which confer E3 ubiquitin ligase and ubiquitin-binding capabilities. This dual function allows TNFAIP3 to remove K63-linked ubiquitin chains from signalling intermediates like RIP1 and TRAF6 and add K48-linked chains, targeting them for proteasomal degradation. By editing these ubiquitin chains, TNFAIP3 inhibits the sustained activation of NF-κB and MAPK pathways, thus preventing excessive inflammation. TNFAIP3 also exhibits anti-apoptotic properties, particularly in pancreatic β-cells and vascular endothelial cells, contributing to cell survival under inflammatory stress. Loss-of-function mutations or decreased expression of TNFAIP3 is associated with heightened susceptibility to autoimmune diseases, chronic inflammatory disorders, and various cancers, particularly B-cell lymphomas. It serves as a tumor suppressor by repressing constitutive NF-κB activity, which drives cell proliferation and survival. Genetic variants in TNFAIP3 are implicated in diseases such as systemic lupus erythematosus, rheumatoid arthritis, psoriasis, and atherosclerosis.

References
[1] Vereecke L, et al. Trends Immunol. 2009 Aug;30(8):383-91.

Reference Table for Selecting PVDF Membrane Pore Size Specifications

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%